What is the smallest intrauterine device (IUD) available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Smallest IUD Available

The 13.5 mg levonorgestrel IUD (Skyla) is the smallest intrauterine device currently available in the United States, approved for 3 years of use. 1

Available IUD Options by Size

The United States currently has five IUDs available, with varying sizes and hormone content 2:

Levonorgestrel-Releasing IUDs (Smallest to Largest)

  • 13.5 mg levonorgestrel IUD (Skyla): The smallest option, releasing 14 mcg per 24 hours, approved for 3 years 1, 3
  • 19.5 mg levonorgestrel IUD: Mid-sized option 2
  • 52 mg levonorgestrel IUDs (Mirena, Liletta): Larger devices releasing 20 mcg per 24 hours, approved for 5-7 years 1, 3

Copper IUD

  • Copper T 380A: Non-hormonal option, approved for 10 years but effective for at least 12 years 4

Why Size Matters: The Anatomical Reality

Most nulliparous women have uterine cavities that are narrower than conventional IUDs, making smaller devices particularly important for this population. 5

Key Anatomical Findings

  • The mean uterine cavity width in nulliparous women is only 22.2 mm (range 6.0-41.1 mm) 5
  • 32% of nulliparous women have cavity widths less than 20 mm 5
  • 6.8% have cavity widths less than 15 mm 5
  • Mean endometrial cavity length is 3.84 cm in nulliparous women versus 4.25 cm in parous women 6

Clinical Implications of Size Mismatch

When IUDs are too large for the uterine cavity, women experience higher rates of 7, 5:

  • Expulsion
  • Embedment
  • Bleeding and pain
  • Early discontinuation (5-year continuation rates only 40-50%)

Clinical Recommendations

The smaller 13.5 mg levonorgestrel IUD (Skyla) is particularly appropriate for nulliparous women and adolescents who may have smaller uterine cavities. 1, 2

Safety in Nulliparous Women

  • The American Academy of Pediatrics confirms that levonorgestrel IUDs are safe for nulliparous adolescents 1
  • IUDs do not cause tubal infertility in nulliparous women 1
  • Rapid return to fertility occurs after removal 1

Consideration for Preprocedural Imaging

Preprocedural 2D or 3D ultrasound to measure uterine cavity width may help select the most appropriate IUD size and maximize continuation rates. 5 This is especially relevant given that one-third of nulliparous women have cavity widths less than 20 mm, which may be too narrow for standard-sized devices 5.

Common Pitfall to Avoid

Do not assume all women can accommodate standard-sized IUDs. Nulliparous women have significantly smaller uterine cavities than parous women, and inserting oversized devices leads to preventable complications and discontinuation 6, 5.

References

Guideline

Levonorgestrel Intrauterine Device (IUD) Contraception and Therapeutic Benefits

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intrauterine devices: an update.

American family physician, 2014

Guideline

Copper IUD Contraceptive Effectiveness Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intrauterine devices and intrauterine systems.

Human reproduction update, 2008

Related Questions

What is the maximum uterine length for safe sounding during Intrauterine Device (IUD) insertion in a 40-year-old parous woman?
What treatment is needed for a patient who had a tampon (intrauterine device) left in for 1 week and now has a lingering odor?
What is the best Intrauterine Device (IUD) for a nulliparous female?
Can an intrauterine device (IUD) cause blockage of the fallopian tubes?
A woman with a copper intrauterine device placed in June presents with two weeks of prolonged vaginal bleeding, a positive urine pregnancy test, transvaginal ultrasound showing the IUD in correct position and no intrauterine gestational sac, an initial quantitative β‑hCG in the 60 IU/L range that fell to the 40 IU/L range, and bleeding that stopped one day ago; what is the appropriate management plan?
What is the management for a patient with green drainage from a suprapubic (urinary catheter inserted through the abdomen) tube site, indicating a potential urinary tract infection (UTI)?
What is the recommended tapering schedule for prednisone based on the patient's current dose?
What is the best approach for anticoagulation in a patient with a deep vein thrombosis (DVT) who stopped taking Eliquis (apixaban) due to occult blood in emesis?
What is the treatment for a suspected cervical epidural abscess or phlegmon?
What is the difference between Mirena (levonorgestrel) and Liletta (levonorgestrel)?
What is the recommended first-line approach for managing agitation in a general inpatient hospice setting?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.